Biomedical Papers-Olomouc最新文献

筛选
英文 中文
CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC). 可切除的非小细胞肺癌(NSCLC)中的 CCL2、CCL8 和 CXCL12 趋化因子。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-12-01 Epub Date: 2023-01-09 DOI: 10.5507/bp.2022.050
Marie Drosslerova, Martina Sterclova, Alice Taskova, Vladislav Hytych, Eva Richterova, Magdalena Bruzova, Miloslav Spunda, Martin Komarc, Martina Koziar Vasakova
{"title":"CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC).","authors":"Marie Drosslerova, Martina Sterclova, Alice Taskova, Vladislav Hytych, Eva Richterova, Magdalena Bruzova, Miloslav Spunda, Martin Komarc, Martina Koziar Vasakova","doi":"10.5507/bp.2022.050","DOIUrl":"10.5507/bp.2022.050","url":null,"abstract":"<p><strong>Background: </strong>Complex networks of chemokines are part of the immune reaction targeted against tumor cells. Chemokines influence cancer growth. It is unclear whether the concentrations of chemokines at the time of NSCLC (non-small cell lung cancer) diagnosis differ from healthy controls and reflect the extent of NSCLC.</p><p><strong>Aims: </strong>To compare chemokine concentrations (CCL2, CCL8, CXCL12) in the plasma of patients with resectable NSCLC to those without cancer. To determine whether the chemokine concentrations differ relative to the stage of disease.</p><p><strong>Methods: </strong>Sixty-nine patients undergoing surgery for proven/suspected NSCLC were enrolled. They underwent standard diagnostic and staging procedures to determine resectability, surgery was performed. Forty-two patients were diagnosed with NSCLC, while 27patients had benign lung lesions and functioned as the control group. Chemokine concentrations in peripheral blood were assessed using ELISA. Parametric statistics were used for the analysis of results.</p><p><strong>Results: </strong>There were no differences in plasma chemokine concentrations in NSCLC patients compared to controls. CXCL12 concentrations correlated positively with tumor extent expressed as clinical stage, (mean values: stage I 5.08 ng/mL, SEM 0.59; stage II and IIIA 7.82 ng/mL; SEM 1.06; P=0.022). Patients with NSCLC stages II+IIIA had significantly higher CXCL12 concentrations than controls (mean values: stage II+IIIA 7.82 ng/mL; SEM 1.06; controls 5.3 ng/mL; SEM 0.46; P=0.017).</p><p><strong>Conclusion: </strong>CXCL12 was related to tumor growth and could potentially be used as a biomarker of advanced disease.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"335-339"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9078857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Current status and future perspectives of oral HPV testing in the diagnosis and monitoring of oropharyngeal cancer. A review. 口腔HPV检测在口咽癌症诊断和监测中的现状和前景。评论。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-12-01 Epub Date: 2023-10-20 DOI: 10.5507/bp.2023.040
Zuzana Horakova, Ivo Starek, Richard Salzman
{"title":"Current status and future perspectives of oral HPV testing in the diagnosis and monitoring of oropharyngeal cancer. A review.","authors":"Zuzana Horakova, Ivo Starek, Richard Salzman","doi":"10.5507/bp.2023.040","DOIUrl":"10.5507/bp.2023.040","url":null,"abstract":"<p><p>HPV16 status in oropharyngeal cancer (OPC) is an important prognostic factor. Its determination, based on immunistochemical analysis of p16 oncoprotein requires an invasive biopsy. Thus, alternative methods are being sought. Determining oral HPV16 status appears to be a promising alternative. However, it is not used routinely. This prompted us to perform a systematic literature review enabling us to evaluate the diagnostic and predictive ability of this approach. Thirty-four relevant studies were finally selected. For determination of HPV status in OPC, the calculated average sensitivity and specificity for oral sampling was 74% and 91%, respectively, with p16 tumour tissue marker being the gold standard. The method appears to be valuable in monitoring treatment response as well as the biological activity of the tumour, enabling early detection of persistent or relapsing carcinoma sufficiently long before its clinical and/or radiological manifestation. It can also contribute to identification of the primary tumour in cases of metastases of unknown origin. Last but not least, the screening HPV oral testing would help to identify individuals with persistent HPV oral infection who are at increased risk of development of OPC.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"319-327"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71415416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overweight and obesity in children and adolescents with endocrine disorders. 患有内分泌失调的儿童和青少年的超重和肥胖症。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-12-01 Epub Date: 2023-09-04 DOI: 10.5507/bp.2023.036
Renata Pomahacova, Petra Paterova, Eva Nykodymova, Petr Polak, Eva Sladkova, Eva Skalicka, Josef Sykora
{"title":"Overweight and obesity in children and adolescents with endocrine disorders.","authors":"Renata Pomahacova, Petra Paterova, Eva Nykodymova, Petr Polak, Eva Sladkova, Eva Skalicka, Josef Sykora","doi":"10.5507/bp.2023.036","DOIUrl":"10.5507/bp.2023.036","url":null,"abstract":"Obesity has become a serious medical condition where many factors can contribute to excess weight gain. The most common type of childhood obesity is simple obesity, which is due to gene-obesogenic environment interaction. Only a minority are due to pathological causes. Secondary causes of obesity, while less common, include these: genetic syndromes, drug-related obesity, as well as endocrine disorders (hypothyroidism, Cushing's syndrome, growth hormone deficiency, hypogonadism, pseudohypoparathyroidism type Ia, insulinoma, hypothalamic obesity and polycystic ovary syndrome). Given that some conditions may be treatable, physicians must be aware of obesity due to endocrinopathies and distinguish them from simple obesity, and treat them properly. Although rare among children, early detection of the endocrine cause of obesity leads to reduced morbidity and, in some cases, reduced mortality in these individuals. The aim of this review is to summarize the current findings on obesity-related endocrinopathies in children (illustrated by clinical examples), highlighting aspects of pathogenetic mechanisms, genetics, the clinical diagnosis, growth, body mass index and possible therapeutic approaches. Early detection and correction of endocrine obesity is of paramount importance for obese children who could benefit from timely diagnosis and an improved management of obesity as many disturbances related to obesity can be reversed at the early stage, if weight loss is achieved.","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"328-334"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10235375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethambutol-induced optic neuropathy. 乙胺丁醇引起的视神经病变。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2022-05-16 DOI: 10.5507/bp.2022.022
Martin Kyncl, Martin Fus, Jan Lestak
{"title":"Ethambutol-induced optic neuropathy.","authors":"Martin Kyncl,&nbsp;Martin Fus,&nbsp;Jan Lestak","doi":"10.5507/bp.2022.022","DOIUrl":"https://doi.org/10.5507/bp.2022.022","url":null,"abstract":"<p><strong>Purpose: </strong>A case report of a 40-year-old patient with tuberculosis treated with ethambutol is described. Within six months of starting treatment, there was a painless sudden decline in visual function. Despite the known complications of ethambutol treatment, it was discontinued after another three months.</p><p><strong>Methods: </strong>In the case report, we highlight the damage to the dominantly peripheral visual pathways. Using electrophysiological examinations, we showed a significant alteration in the optic nerves. Optical Coherence Tomography (OCT) showed progressive loss of vessel density and nerve fibre layer of retinal ganglion cells. Perimetric examination showed both a central decrease in sensitivity and mainly scotomas in the temporal parts of the visual fields. Although there was improvement in visual fields over time, OCT findings indicated progression of ethambutol-induced optic neuropathy (EON). Magnetic Resonance Imaging confirmed the alteration in the peripheral part of the visual pathway (intraorbital, intracranial parts of optic nerves, chiasma, and optic tracts).</p><p><strong>Conclusion: </strong>Even though EON is not an unknown complication, new cases still occur and, unfortunately, with an irreversible course. Therefore, it is important to draw attention constantly to this complication and to consider it not only in ophthalmologists' surgeries.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":"167 3","pages":"288-293"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk stratification using growth differentiation factor 15 in patients undergoing transcatheter aortic valve implantation. 应用生长分化因子15对接受经导管主动脉瓣植入术的患者进行风险分层。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2022-04-12 DOI: 10.5507/bp.2022.017
Martin Sluka, Martin Hutyra, Radomir Nykl, Jiri Ostransky, Tomas Furst, Pavla Petrova, Jan Precek, Stepan Hudec, Milos Taborsky
{"title":"Risk stratification using growth differentiation factor 15 in patients undergoing transcatheter aortic valve implantation.","authors":"Martin Sluka,&nbsp;Martin Hutyra,&nbsp;Radomir Nykl,&nbsp;Jiri Ostransky,&nbsp;Tomas Furst,&nbsp;Pavla Petrova,&nbsp;Jan Precek,&nbsp;Stepan Hudec,&nbsp;Milos Taborsky","doi":"10.5507/bp.2022.017","DOIUrl":"https://doi.org/10.5507/bp.2022.017","url":null,"abstract":"<p><strong>Aims: </strong>Growth differentiation factor 15 (GDF15) shows potential predictive value in various cardiac conditions. We investigated relationships between GDF15 and clinical or procedural outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) in order to propose clinically useful predictive risk stratification model.</p><p><strong>Methods: </strong>This prospective single-center registry enrolled 88 consecutive patients with severe symptomatic aortic stenosis treated with TAVI. Clinical parameters were collected and biomarkers including GDF-15 were measured within 24 h before TAVI. All relevant clinical outcomes according to the Valve Academic Research Consortium-2 were collected over the follow-up period.</p><p><strong>Results: </strong>The cohort included 52.3% of females. The mean age of study participants was 81 years; the mean Society of Thoracic Surgeons (STS) score and logistic EuroSCORE were 3.6% and 15.4%, respectively. The mortality over the entire follow-up period was 10.2%; no death was observed within the first 30 days following TAVI. Univariate analysis showed significant associations between GDF15 and mortality (P=0.0006), bleeding (P=0.0416) and acute kidney injury (P=0.0399). A standard multivariate logistic regression model showed GDF-15 as the only significant predictor of mortality (P=0.003); the odds ratio corresponding to an increase in GDF15 of 1000 pg/mL was 1.22. However, incremental predictive value was not observed when the STS score was combined with GDF15 in this predictive model.</p><p><strong>Conclusions: </strong>Based on our observations, preprocedural elevated GDF15 levels are associated with increased mortality and demonstrate their additional value in predicting adverse clinical outcomes in a TAVI population.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":"167 3","pages":"263-271"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry. ICD治疗在实际临床实践中的有效性。Olomouc ICD注册处。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2021-12-17 DOI: 10.5507/bp.2021.071
Milos Taborsky, Tomas Skala, Marian Fedorco, Vlastimil Doupal, Ingrid Sovova, Jiri Jarkovsky, Klara Benesova, Monika Bezdekova, Marek Vicha, Josef Danek, Josef Kautzner
{"title":"Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry.","authors":"Milos Taborsky,&nbsp;Tomas Skala,&nbsp;Marian Fedorco,&nbsp;Vlastimil Doupal,&nbsp;Ingrid Sovova,&nbsp;Jiri Jarkovsky,&nbsp;Klara Benesova,&nbsp;Monika Bezdekova,&nbsp;Marek Vicha,&nbsp;Josef Danek,&nbsp;Josef Kautzner","doi":"10.5507/bp.2021.071","DOIUrl":"10.5507/bp.2021.071","url":null,"abstract":"<p><strong>Background: </strong>Clinical parameters linked to a low benefit of ICD implantation and increased mortality risks are needed for an individualized assessment of potential benefits and risks of ICD implantation.</p><p><strong>Methods: </strong>Analysis of a prospective registry of all patients hospitalized from 2009 to 2019 in a single centre for a first implantation of any type of ICD.</p><p><strong>Results: </strong>A total of 2,681 patients were included in the registry. Until the end of follow-up (38.4 ± 29.1 months), 682 (25.4%) patients died. The one-year mortality in all patients, the one-year CV mortality, the three-year mortality in all patients, and the three-year CV mortality were 7.8%, 5.7%, 20.6%, and 14.8%, respectively. There was a statistically significant difference when the subgroups were compared according to the type of cardiomyopathy. No significant difference was found between primary and secondary prevention and between the types of devices. Male gender, age ≥ 75 years, diabetes mellitus, and atrial fibrillation were associated with a significantly increased mortality risk.</p><p><strong>Conclusion: </strong>In an analysis of a long-term follow-up of 2,681 ICD patients, we found no mortality difference between patients with ischemic or non-ischemic cardiomyopathy and in the device type. A higher mortality risk was found in men, patients older than 75 years, diabetics, and those with atrial fibrillation.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"225-235"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39821265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Infectious complications of induction treatment for acute myeloid leukaemia using the "7 + 3" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site. 使用“7+3”方案在没有抗生素预防的情况下诱导治疗急性髓细胞白血病的感染性并发症-一个临床站点的15年经验。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2022-03-01 DOI: 10.5507/bp.2022.010
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak, Tomas Papajik
{"title":"Infectious complications of induction treatment for acute myeloid leukaemia using the \"7 + 3\" protocol without antibiotic prophylaxis - 15 years of experience of one clinical site.","authors":"Martin Cernan,&nbsp;Tomas Szotkowski,&nbsp;Jaromir Hubacek,&nbsp;Milan Kolar,&nbsp;Edgar Faber,&nbsp;Karel Indrak,&nbsp;Tomas Papajik","doi":"10.5507/bp.2022.010","DOIUrl":"https://doi.org/10.5507/bp.2022.010","url":null,"abstract":"<p><strong>Background: </strong>Infectious complications during induction chemotherapy of acute myeloid leukaemia are very common. Prophylactic use of antibiotics however is an ongoing challenge in this situation due to bacterial multi-drug resistance. The aim of this study was to provide a comprehensive overview of the incidence of infectious complications in patients with AML undergoing induction therapy using the \"7+3\" protocol without routine antibiotic prophylaxis at one clinical site providing specialised haematological care in the Czech Republic, over a period of 15 years. The study also evaluates the aetiological spectrum of causative agents and the development of antibiotic resistance in the context of the use of the various classes of antibiotics. The analysis includes evaluation of the importance of risk factors for infectious complications and their impact on treatment of the underlying disease. The data are compared with published figures for similar cohorts of patients.</p><p><strong>Patients and methods: </strong>This study presents a retrospective analysis of infectious complications in 242 patients with acute myeloid leukaemia undergoing the first cycle of induction therapy without routine antibiotic prophylaxis in one clinical site in Czech Republic during years 2006-2020.</p><p><strong>Results: </strong>A total of 363 febrile episodes (FE) were recorded. At least 1 FE during the induction was detected in 229 (94.6%) patients. Clinically defined infection was the cause in 96 (26.4%) FEs and blood stream infection in 69 (19.0%) FEs. Both complications occurred simultaneously in 29 (8.0%) FEs. 169 (46.6%) FEs were evaluated as fever of unknown origin (FUO). The achievement of complete remission had a significant effect on the duration of the FE (6 vs. 9 days, P=0.0005) and on the overall survival duration (79.3 vs. 6.5 months, P<0.0001). Patients diagnosed with infection or FUO at diagnosis were significantly more likely to suffer from colonisation by multi-drug resistant bacterial strains at discharge (29.2% vs. 16.3%, P=0.022). This group of patients used antibiotic therapy for a significantly longer time (35 vs. 23 days, P<0.0001). Infection was a contributing cause of death in 18 (7.4%) patients. Mortality was significantly related to the failure to achieve complete remission (P<0.0001).</p><p><strong>Conclusion: </strong>Infectious mortality during induction treatment without routine antibiotic prophylaxis was comparable to the published cohorts with prophylaxis. Regular microbiology surveillance with adequate initial antibiotic treatment can compensate routine antibiotic prophylaxis with slower development of antibiotic resistance.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":"167 3","pages":"236-245"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71429420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ascorbic acid intake during pregnancy. 孕期抗坏血酸摄入量。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2023-09-06 DOI: 10.5507/bp.2023.035
Kristina Podolska, Dana Mazankova, Maria Goboova, Ivan Vano
{"title":"Ascorbic acid intake during pregnancy.","authors":"Kristina Podolska,&nbsp;Dana Mazankova,&nbsp;Maria Goboova,&nbsp;Ivan Vano","doi":"10.5507/bp.2023.035","DOIUrl":"10.5507/bp.2023.035","url":null,"abstract":"<p><p>The continuing global increase in allergic conditions and diseases in children is now a serious public health and scientific issue. Amongst other concerns is the maternal antenatal diet as intake of essential nutrients. Even small deficits in essential vitamin C can permanently impair the developing brain for example. In this article, we first review ascorbic acid deficiency in different organs of both mother and foetus. However, major emphasis is on the importance of vitamin C in foetal immunity with studies showing an inverse relationship between maternal intake of fresh fruit and vegetables and allergic conditions in childhood, inter alia. Other review results are included.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"213-218"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10205422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Probiotics and the microbiota-gut-brain axis: focus on patients with depression. A review of current research. 益生菌和微生物群肠脑轴:关注抑郁症患者。当前研究综述。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2023-06-14 DOI: 10.5507/bp.2023.024
Cristina Macrea, Tiberia Ilias, Ovidiu Fratila, Brata Roxana, Cristian Hocopan
{"title":"Probiotics and the microbiota-gut-brain axis: focus on patients with depression. A review of current research.","authors":"Cristina Macrea,&nbsp;Tiberia Ilias,&nbsp;Ovidiu Fratila,&nbsp;Brata Roxana,&nbsp;Cristian Hocopan","doi":"10.5507/bp.2023.024","DOIUrl":"10.5507/bp.2023.024","url":null,"abstract":"<p><p>This review covers recent data on the relationship between major depressive disorder (MDD) and faecal microbiome and examines the co-relations between the use of probiotics and changes in psychiatric state. We conducted a thorough search of academic databases for articles published between 2018 and 2022, using specific keywords and previously established inclusion/exclusion criteria regarding faecal microbiota, depressive disorder, and probiotics. Of 192 eligible articles (reviews, original papers, and clinical trials), we selected 10 that fully met our criteria and performed a careful review to determine any correlation between microbiome, probiotic treatment, and depression. All patients were adults (mean age, 36.8), with at least one MDD episode and onset of depression during adolescence (duration of 31.39 years of depressive episodes). We found mixed but mostly positive results regarding the influence of probiotic/prebiotic/postbiotic effects on depression. We could not identify the precise mechanism of action that led to their improvement. Antidepressants did not alter the microbiota, according to studies that evaluated this aspect. Probiotic/prebiotic/postbiotic treatments were proven to be safe, with few and mild side effects. Probiotics seemingly could be beneficial in patients with depression, as evidenced by well-established depression scales. Based on this finding and the high tolerability and safety of probiotics, no caveats against their routine use can be made. Some unmet needs in this field include determination of the dominant type of microbiota in specific patients with depression; study of microbiome-directed/driven treatment regarding dose and duration adjustments; and multiple versus single strain treatments.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"219-224"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9631283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute drug intoxication in childhood: a 10-year retrospective observational single-centre study and case reports. 儿童急性药物中毒:一项为期10年的回顾性观察性单中心研究和病例报告。
IF 0.9 4区 医学
Biomedical Papers-Olomouc Pub Date : 2023-09-01 Epub Date: 2023-07-21 DOI: 10.5507/bp.2023.032
Petra Matalova, Michal Buchta, Vendula Drietomska, Alena Spicakova, Martin Wawruch, Peter Ondra, Karel Urbanek
{"title":"Acute drug intoxication in childhood: a 10-year retrospective observational single-centre study and case reports.","authors":"Petra Matalova,&nbsp;Michal Buchta,&nbsp;Vendula Drietomska,&nbsp;Alena Spicakova,&nbsp;Martin Wawruch,&nbsp;Peter Ondra,&nbsp;Karel Urbanek","doi":"10.5507/bp.2023.032","DOIUrl":"10.5507/bp.2023.032","url":null,"abstract":"<p><strong>Background: </strong>Medication poisoning in children is a severe condition that can endanger a child's life. Although drug intoxications are easily preventable, awareness of the proper handling of drugs and their safe storage out of the reach of children is not widespread among the general public. In this work, we investigated the demographic and clinical data of children admitted to the Department of Pediatrics of the University Hospital Olomouc for acute drug-induced intoxication. We also selected several case reports to illustrate the wide range of both presentations and outcomes in individual patients.</p><p><strong>Method: </strong>Cases of drug-induced intoxications were selected from a group of patients under the age of 19 years admitted to the hospital for poisoning between January 1, 2010, and December 31, 2019. Medical records of these patients were prospectively evaluated, and overview tables and graphs of predefined research objectives were created.</p><p><strong>Results: </strong>During the given time period, 162 children with suspected drug intoxications were hospitalized at the Department of Pediatrics, University Hospital Olomouc. Of these, 108 cases were reported in girls and 54 in boys (66.7% vs. 33.3%). In 16 cases (9.9%), there was a severe intoxication requiring follow-up intensive care. There was also one case of fatal accidental intoxication. Most poisonings were seen in toddlers (65; 40.1%). Intoxication with suicidal ideation was found in 44 cases (27.2%), with a higher incidence of suicide attempts in girls (40 vs. 4). Repeated intoxication was recorded in nine cases. Analgesics were the most common drug group (61; 37.7%), with paracetamol (28; 17.3%) being the leading drug. In 154 cases (95.1%), the drugs were taken orally, most often in the form of tablets.</p><p><strong>Conclusion: </strong>Accidental drug intoxications most frequently occurred in the age group from one to three years old. The second highest incidence was among adolescents most of which were suicide attempts. Analgesics and psychoactive agents accounted for the majority of cases. Medications should be kept in places where children cannot reach them.</p>","PeriodicalId":55363,"journal":{"name":"Biomedical Papers-Olomouc","volume":" ","pages":"294-302"},"PeriodicalIF":0.9,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信